Filing Flows › Clover Health Investments (CLOV) › Q3 2026 › vs Q3 2025
Clover Health Investments (CLOV) Q3 2026 vs Q3 2025 (year over year)
Clover Health Investments's revenue rose $263M (+53%) from $497M in Q3 2025 to $759M in Q3 2026. Operating margin 0.8% against -4.9% (+5.8 pts).
Clover Health Investments, Q3 2026: revenue $759M (+53% year over year), operating margin 0.8%, net earnings $6.4M, operating cash flow $70.4M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 0.8% | -4.9% | +5.8 pts |
| Net margin | 0.8% | -4.9% | +5.8 pts |
| Free cash flow margin | 9.2% | 2.3% | +6.9 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $759M | $497M | $263M | +53% |
| Operating profit | $6.4M | −$24.4M | $30.8M | — |
| Costs & expenses | $753M | $521M | $232M | +44% |
| Pre-tax earnings | $6.4M | −$24.4M | $30.8M | — |
| General & admin | $66.8M | $49.0M | $17.9M | +37% |
| Other operating costs | $686M | $472M | $214M | +45% |
| Net earnings | $6.4M | −$24.4M | $30.8M | — |
| Share-based compensation | $8.0M | $26.1M | −$18.1M | -69% |
| Working capital & other | $55.9M | $10.4M | $45.5M | +439% |
| Operating cash flow | $70.4M | $12.1M | $58.3M | +482% |
| Free cash flow (OCF − capex) | $69.5M | $11.4M | $58.1M | +509% |
| Capital expenditures | $898K | $692K | $206K | +30% |
Questions
How much did Clover Health Investments's revenue grow year over year in Q3 2026?
Clover Health Investments's revenue rose $263M (+53%) from $497M in Q3 2025 to $759M in Q3 2026. Operating margin 0.8% against -4.9% (+5.8 pts).